Landscape phages and their fusion proteins targeted to breast cancer cells

Protein Engineering, Design and Selection

Volumn 25, Issue 6, 2012, Pages 271-283

  Fagbohun, Olusegun A ^a   Bedi, Deepa ^a   Grabchenko, Natalia I ^a   Deinnocentes, Patricia A ^a   Bird, Richard C ^a   Petrenko, Valery A ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

breast cancer; landscape phage; nucleolin; phage display; phage library

Indexed keywords

BREAST CANCER; LANDSCAPE PHAGES; NUCLEOLIN; PHAGE DISPLAY; PHAGE LIBRARIES;

AFFINITY CHROMATOGRAPHY; BACTERIOPHAGES; CELL MEMBRANES; DISEASES; LIGANDS; PEPTIDES;

CYTOLOGY;

HYBRID PROTEIN; NUCLEOLIN;

AFFINITY CHROMATOGRAPHY; ARTICLE; BREAST CARCINOMA; BREAST CELL; CANCER CELL; CELL INTERACTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INTERNALIZATION; MOLECULAR MECHANICS; MOLECULAR PROBE; PEPTIDE LIBRARY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ISOLATION; SEQUENCE ANALYSIS; TUMOR XENOGRAFT;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; BACTERIOPHAGES; BREAST NEOPLASMS; CAPSID PROTEINS; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; FEMALE; HEP G2 CELLS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PEPTIDES; PHOSPHOPROTEINS; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS; RNA-BINDING PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA; MUS;

EID: 84861614064     PISSN: 17410126     EISSN: 17410134     Source Type: Journal    
DOI: 10.1093/protein/gzs013     Document Type: Article

References (48)

1. Abbineni, G., Modali, S., Safiejko-Mroczka, B., Petrenko, V.A. and Mao, C. (2010) Mol. Pharm., 7, 1629-1642.
2. Agarwal, A., Jaye, D.L., Giegerman, C.M. and Bellamkonda, R.V. (2008) J. Biomed. Mater. Res. A, 87, 728-738.
3. Allen, T.M. (2002) Nat. Rev. Cancer, 2, 750-763.
4. Arap, W., Pasqualini, R. and Ruoslahti, E. (1998) Science, 279, 377-380.
5. Balestrieri, M.L. and Napoli, C. (2007) Eur. J. Cancer, 43, 1242-1250.
6. Bedi, D., Musacchio, T., Fagbohun, O.A., Gillespie, J.W., Deinnocentes, P., Bird, R.C., Bookbinder, L., Torchilin, V.P. and Petrenko, V.A. (2011) Nanomedicine, 7, 315-323.
7. Brigati, J.R., Samoylova, T.I., Jayanna, P.K. and Petrenko, V.A. (2008) In Coligan, J.E., Dunn, B.M., Speicher, D.W. and Wingfield, P.T. (eds), Current Protocols in Protein Science. John Wiley & Sons, Inc, New Jersey, pp. 1-27.
8. Christian, S., Pilch, J., Akerman, M.E., Porkka, K., Laakkonen, P. and Ruoslahti, E. (2003) J. Cell Biol., 163, 871-878.
9. Haley, B. and Frenkel, E. (2008) Urol. Oncol.: Semin. Orig. Investig. 26, 57-64.
10. Healy, J.M., Murayama, O., Maeda, T., Yoshino, K., Sekiguchi, K. and Kikuchi, M. (1995) Biochemistry, 34, 3948-3955.
11. Huang, C., Liu, X.Y., Rehemtulla, A. and Lawrence, T.S. (2005) Int. J. Radiat. Oncol. Biol. Phys., 62, 1497-1503.
12. Ivanenkov, V., Felici, F. and Menon, A.G. (1999a) Biochim. Biophys. Acta, 1448, 450-462.
13. Ivanenkov, V.V., Felici, F. and Menon, A.G. (1999b) Biochim. Biophys. Acta, 1448, 463-472.
14. Jayanna, P.K., Torchilin, V.P. and Petrenko, V.A. (2009) Nanomedicine, 5, 83-89.
15. Jayanna, P.K., Bedi, D., Deinnocentes, P., Bird, R.C. and Petrenko, V.A. (2010a) Protein Eng. Des. Sel., 23, 423-430.
16. Jayanna, P.K., Bedi, D., Gillespie, J.W., DeInnocentes, P., Wang, T., Torchilin, V.P., Bird, R.C. and Petrenko, V.A. (2010b) Nanomedicine, 6, 538-546.
17. Jemal, A., Siegel, R., Xu, J. and Ward, E. (2010) CA Cancer J. Clin., 60, 277-300.
18. Kim, Y., Lillo, A.M., Steiniger, S.C., et al. (2006) Biochemistry, 45, 9434-9444.
19. Koivunen, E., Gay, D.A. and Ruoslahti, E. (1993) J. Biol. Chem., 268, 20205-20210.
20. Kolonin, M.G., Sun, J., Do, K.-A., Vidal, C.I., Ji, Y., Baggerly, K.A., Pasqualini, R. and Arap, W. (2006) FASEB J., 20, 979-981.
21. Kraft, S., Diefenbach, B., Mehta, R., Jonczyk, A., Luckenbach, G.A. and Goodman, S.L. (1999) J. Biol. Chem., 274, 1979-1985.
22. Kubo, N., Akita, N., Shimizu, A., Kitahara, H., Parker, A.L. and Miyagawa, S. (2008) J. Drug Target, 16, 396-404.
23. Kuzmicheva, G.A., Jayanna, P.K., Sorokulova, I.B. and Petrenko, V.A. (2009) Protein Eng. Des. Sel., 22, 9-18.
24. Mandava, S., Makowski, L., Devarapalli, S., Uzubell, J. and Rodi, D.J. (2004) Proteomics, 4, 1439-1460.
25. Maruta, F., Parker, A.L., Fisher, K.D., Hallissey, M.T., Ismail, T., Rowlands, D.C., Chandler, L.A., Kerr, D.J. and Seymour, L.W. (2002) Cancer Gene Ther., 9, 543-552.
26. Mori, T. (2004) Curr. Pharm. Des., 10, 2335-2343.
27. Noppe, W., Plieva, F.M., Galaev, I.Yu., Vanhoorelbeke, K., Mattiasson, B. and Deckmyna, H. (2006) J. Chromatogr. A, 1101, 79-85.
28. Pasqualini, R., Koivunen, E. and Ruoslahti, E. (1995) J. Cell Biol., 130, 1189-1196.
29. Passarella, R.J., Zhou, L., Phillips, J.G., Wu, H., Hallahan, D.E. and Diaz, R. (2009) Clin. Cancer Res., 15, 6421-6429.
30. Petrenko, V. (2008) Expert Opin. Drug Deliv., 5, 825-836.
31. Petrenko, V.A. and Jayanna, P.K. (2011) In Petrenko, V.A. and Smith, G.P. (eds), Phage Nanobiotechnology. Royal Society of Chemistry, Cambridge, pp. 55-82.
32. Petrenko, V.A., Smith, G.P., Gong, X. and Quinn, T. (1996) Protein Eng., 9, 797-801.
33. Romanov, V.I., Durand, D.B. and Petrenko, V.A. (2001) Prostate, 47, 239-251.
34. Ru, B., Huang, J., Dai, P., Li, S., Xia, Z., Ding, H., Lin, H., Guo, F. and Wang, X. (2010) Molecules, 15, 8279-8288.
35. Ruoslahti, E. (1996) Annu. Rev. Cell Dev. Biol., 12, 697-715.
36. Samoylova, T.I., Petrenko, V.A., Morrison, N.E., Globa, L.P., Baker, H.J. and Cox, N.R. (2003) Mol Cancer Ther, 2, 1129-1137.
37. Sergeeva, A., Kolonin, M.G., Molldrem, J.J., Pasqualini, R. and Arap, W. (2006) Adv. Drug Deliv. Rev., 58, 1622-1654.
38. Shukla, G.S. and Krag, D.N. (2010) Protein Eng. Des. Sel. 6 431-440.
39. Vasir, J.K. and Labhasetwar, V. (2005) Technol. Cancer Res. Treat., 4, 363-374.
40. Wang, T., D'Souza, G.G., Bedi, D., Fagbohun, O.A., Potturi, L.P., Papahadjopoulos-Sternberg, B., Petrenko, V.A. and Torchilin, V.P. (2010a) Nanomedicine (Lond.), 5, 563-574.
41. Wang, T., Petrenko, V.A. and Torchilin, V.P. (2010b) Mol. Pharm., 7, 1007-1014.
42. Wang, T., Yang, S., Petrenko, V.A. and Torchilin, V.P. (2010c) Mol. Pharm., 7, 1149-1158.
43. Wang, T., Kulkarni, N., Bedi, D., D'Souza, G.G., Papahadjopoulos- Sternberg, B., Petrenko, V.A. and Torchilin, V.P. (2011a) J. Drug Target, 19, 597-605.
44. Wang, T., Kulkarni, N., D'Souza, G.G., Petrenko, V.A. and Torchilin, V.P. (2011b) Mol. Pharm., 8, 1720-1728.
45. Welply, J.K., Steininger, C.N., Caparon, M., et al. (1996) Proteins, 26, 262-270.
46. Witt, H., Hajdin, K., Iljin, K., Greiner, O., Niggli, F.K., Schafer, B.W. and Bernasconi, M. (2009) Int. J. Cancer, 124, 2026-2032.
47. Wu, P., Leinonen, J., Koivunen, E., Lankinen, H. and Stenman, U.H. (2000) Eur. J. Biochem., 267, 6212-6220.
48. Zou, J., Glinsky, V.V., Landon, L.A., Matthews, L. and Deutscher, S.L. (2005) Carcinogenesis, 26, 309-318. Landscape phages and their fusion proteins